SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-018528
Filing Date
2022-05-06
Accepted
2022-05-06 13:42:38
Documents
82
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eypt-10q_20220331.htm   iXBRL 10-Q 2247501
2 EX-31.1 eypt-ex311_8.htm EX-31.1 18956
3 EX-31.2 eypt-ex312_10.htm EX-31.2 19147
4 EX-32.1 eypt-ex321_7.htm EX-32.1 6170
5 EX-32.2 eypt-ex322_11.htm EX-32.2 6189
  Complete submission text file 0001564590-22-018528.txt   9640328

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA eypt-20220331.xsd EX-101.SCH 73306
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eypt-20220331_cal.xml EX-101.CAL 63204
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eypt-20220331_def.xml EX-101.DEF 249215
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE eypt-20220331_lab.xml EX-101.LAB 535707
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eypt-20220331_pre.xml EX-101.PRE 411479
76 EXTRACTED XBRL INSTANCE DOCUMENT eypt-10q_20220331_htm.xml XML 1941311
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51122 | Film No.: 22900255
SIC: 3826 Laboratory Analytical Instruments
Industrial Applications and Services